[Pharmacologic evaluation of 3-butoxy-l-phenoxy-propanol-(2), a new substance with choleretic activity].
D000433:1-Propanol / Q000494:pharmacology / Q000633:toxicity; D000818:Animals; D000927:Anticonvulsants; D001646:Bile / Q000378:metabolism; D001647:Bile Acids and Salts / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D002415:Cats; D002756:Cholagogues and Choleretics / Q000494:pharmacology* / Q000633:toxicity; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004597:Electroshock; D005260:Female; D006168:Guinea Pigs; D006937:Hypercholesterolemia / Q000378:metabolism; D066298:In Vitro Techniques; D007928:Lethal Dose 50; D050356:Lipid Metabolism; D008099:Liver / Q000187:drug effects; D008297:Male; D051379:Mice; D010647:Phenyl Ethers / Q000494:pharmacology*; D051381:Rats; D013045:Species Specificity
D000927:Anticonvulsants; D001647:Bile Acids and Salts; D002756:Cholagogues and Choleretics; D010647:Phenyl Ethers; D000433:1-Propanol
Zur Pharmakologie von 3-Butoxy-l-phenoxy-propanol-(2), einer neuen Substanz mit choleretischer Wirkung.